CN Patent

CN104407067A — 依鲁替尼及其异构体的检测方法

Assigned to Ruyuan Hec Pharm Co ltd · Expires 2015-03-11 · 11y expired

What this patent protects

本发明涉及一种依鲁替尼及其对映异构体杂质的液相分离检测方法，属于分离检测技术领域。所述检测方法包括：采用 AD-H，4.6mm X250mm，5μm，手性色谱柱为分离色谱柱；以烷烃溶剂和醇溶剂的混合溶剂为流动相，烷烃溶剂与醇溶剂的体积比为35:65。所述方法可以有效的分离检测依鲁替尼及其对映异构体杂质，分离度达5以上，能够用于生产中。

USPTO Abstract

本发明涉及一种依鲁替尼及其对映异构体杂质的液相分离检测方法，属于分离检测技术领域。所述检测方法包括：采用 AD-H，4.6mm X250mm，5μm，手性色谱柱为分离色谱柱；以烷烃溶剂和醇溶剂的混合溶剂为流动相，烷烃溶剂与醇溶剂的体积比为35:65。所述方法可以有效的分离检测依鲁替尼及其对映异构体杂质，分离度达5以上，能够用于生产中。

Drugs covered by this patent

Patent Metadata

Patent number
CN104407067A
Jurisdiction
CN
Classification
—
Expires
2015-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Ruyuan Hec Pharm Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.